MARKET

ABBV

ABBV

Abbvie Inc
NYSE
209.17
+3.88
+1.89%
Opening 15:19 03/31 EDT
OPEN
204.43
PREV CLOSE
205.29
HIGH
210.81
LOW
204.43
VOLUME
5.26M
TURNOVER
--
52 WEEK HIGH
218.66
52 WEEK LOW
149.57
MARKET CAP
370.01B
P/E (TTM)
87.51
1D
5D
1M
3M
1Y
5Y
1D
AbbVie: Margin Expansion Potential Can Support Elevated P/E
Seeking Alpha · 4h ago
PGIM Jennison Value Fund Q4 2024 Commentary
Seeking Alpha · 5h ago
Meta, Snowflake, PayPal And Health Care Stock On CNBC's 'Final Trades'
Benzinga · 6h ago
AbbVie to Host First-Quarter 2025 Earnings Conference Call
PR Newswire · 7h ago
Should You Invest in the Vanguard Health Care ETF (VHT)?
NASDAQ · 8h ago
Weekly Report: what happened at ABBV last week (0324-0328)?
Weekly Report · 10h ago
Want $1 Million in Retirement? 3 Stocks to Buy Now and Hold for Decades.
The Motley Fool · 10h ago
Eli Lilly Vs. Novo Nordisk: Which Is The Better Bargain For Investors
Seeking Alpha · 1d ago
More
About ABBV
More
AbbVie Inc. is a global, diversified research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. Its product portfolio includes Immunology, Oncology, Aesthetics, Neuroscience, Eye Care and Other Key Products. Its Immunology products include rheumatology, dermatology and gastroenterology. Its Oncology products include Imbruvica, Venclexta/Venclyxto, Elahere, and Epkinly. The Company’s Aesthetics portfolio consists of facial injectables, plastics and regenerative medicine, body contouring, and skincare products. Its Neuroscience products include Botox Therapeutic, Vraylar, Duopa and Duodopa, Ubrelvy, and Qulipta. Its Eye Care products include Ozurdex, Lumigan/Ganfort, Alphagan/Combigan, Restasis, and Other eye care. Its Other key products include Mavyret/Maviret, Creon, and Linzess/Constella. Its Venclexta is a B-cell lymphoma 2 (BCL-2) inhibitor used to treat blood cancers.
Recently
Symbol
Price
%Change

Webull offers AbbVie Inc stock information, including NYSE: ABBV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ABBV stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ABBV stock methods without spending real money on the virtual paper trading platform.